Differential Diagnoses

Child Sexual Abuse
Childhood-Onset Schizophrenia
Conduct Disorder
Dissociative Identity Disorder
Pediatric Ethanol Toxicity
Hyponatremia in Emergency Medicine
Bacterial Meningitis Imaging
LSD Toxicity
Oppositional Defiant Disorder
Oral Hypoglycemic Agent Toxicity
Pediatric Aseptic Meningitis
Pediatric Bipolar Affective Disorder
Pediatric Cocaine Abuse
Pediatric Depression
Pediatric Generalized Anxiety Disorder
Pediatric Hypoglycemia
Pediatric Metabolic Acidosis
Pediatric Panic Disorder
Personality Disorder: Avoidant Personality
Personality Disorder: Borderline
Toxicity, Mushrooms - Muscarine

Workup

Freese TE, Miotto K, Reback CJ. The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment. J Subst Abuse Treat. September 2002. 23(2):151-6. [Medline]. [Full Text].
Smith KM, Larive LL, Romanelli F. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate. Am J Health-Syst Pharm. June 2002. 59(11):1067-76. [Medline].
Wallach J, De Paoli G, Adejare A, Brandt SD. Preparation and analytical characterization of 1-(1-phenylcyclohexyl)piperidine (PCP) and 1-(1-phenylcyclohexyl)pyrrolidine (PCPy) analogues. Drug Test Anal. 2014 Jul-Aug. 6 (7-8):633-50. [Medline].
Misra AL, Pontani RB, Bartolomeo J. Persistence of phencyclidine (PCP) and metabolites in brain and adipose tissue and implications for long-lasting behavioural effects. Res Commun Chem Pathol Pharmacol. 1979 Jun. 24(3):431-45. [Medline].
Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975-2006: Volume I, Secondary school students 2006. National Institute on Drug Abuse. September 2007. Available at http://www.monitoringthefuture.org/pubs/monographs/vol1_2006.pdf.
Hallucinogens. National Institute on Drug Abuse. Available at http://www.drugabuse.gov/drugs-abuse/hallucinogens. Accessed: December 30, 2014.
Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila). 2020 Dec. 58 (12):1360-1541. [Medline]. [Full Text].
Drug Abuse Warning Network. Emergency Department Visits Involving Phencyclidine (PCP). The Drug Abuse Warning Network Report. Available at https://www.samhsa.gov/data/sites/default/files/DAWN143/DAWN143/sr143-emergency-phencyclidine-2013.pdf. November 12, 2013; Accessed: February 2, 2018.
Results from the 2016 National Survey on Drug Use and Health:Summary of National Findings. Substance Abuse and Mental Health Services Administration. Available at https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf. Accessed: February 2, 2019.
Substance Abuse and Mental Health Services Administration. Results from the 2014 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. Available at https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2014/NSDUH-DetTabs2014.pdf. Accessed: November 22, 2016.
McCarron MM, Schulze BW, Thompson GA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med. 1981 May. 10(5):237-42. [Medline].
Akmal M, Valdin JR, McCarron MM. Rhabdomyolysis with and without acute renal failure in patients with phencyclidine intoxication. Am J Nephrol. 1981. 1(2):91-6. [Medline].
Schifano F, Corkery J, Oyefeso A, Tonia T, Ghodse AH. Trapped in the "K-hole": Overview of Deaths Associated With Ketamine Misuse in the UK (1993-2006). J Clin Psychopharmacol. February 2008. 28(1):114-16. [Medline].
Barton CH, Sterling ML, Vaziri ND. Phencyclidine intoxication: clinical experience in 27 cases confirmed by urine assay. Ann Emerg Med. 1981 May. 10(5):243-6. [Medline].
Gonzalez-Maeso J, Sealfon SC. Psychedelics and schizophrenia. Trends Neurosci. 2009 Apr. 32(4):225-32. [Medline].
Yago KB, Pitts FN Jr, Burgoyne RW, Aniline O, Yago LS, Pitts AF. The urban epidemic of phencyclidine (PCP) use: clinical and laboratory evidence from a public psychiatric hospital emergency service. J Clin Psychiatry. May 1981. 42(5):193-6. [Medline].
Hoaken PN, Stewart SH. Drugs of abuse and the elicitation of human aggressive behavior. Addict Behav. 2003 Dec. 28(9):1533-54. [Medline].
Schwartz RH, Einhorn A. PCP intoxication in seven young children. Pediatr Emerg Care. 1986 Dec. 2(4):238-41. [Medline].
Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ, Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend. June 2008. 95(3):219-29. [Medline].
Piecuch S, Thomas U, Shah BR. Acute dystonic reactions that fail to respond to diphenhydramine: think of PCP. J Emerg Med. May-Jun 1999. 17(3):379-81. [Medline].
[Guideline] Bukstein OG, Bernet W, Arnold V, Beitchman J, Shaw J, Benson RS, et al. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry. 2005 Jun. 44(6):609-21. [Medline]. [Full Text].
Picchioni AL, Consroe PF. Activated charcoal--a phencyclidine antidote, or hog in dogs. N Engl J Med. 1979 Jan 25. 300(4):202. [Medline].
Fauman B, Baker F, Coppleson LW. Psychosis-induced by phencyclidine. JACEP. 1975. 4:223-5.

Media Gallery

Phenylcyclohexyl piperidine (PCP), also known as phencyclidine, in tablet form. Image courtesy of the US Drug Enforcement Administration.

of 1

Author

Stephan Brenner, MD, MPH Resident Physician, Department of Emergency Medicine, Washington University in St Louis School of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

William H Dribben, MD Assistant Professor, Division of Emergency Medicine, Washington University in St Louis School of Medicine

William H Dribben, MD is a member of the following medical societies: American Academy of Emergency Medicine, Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Jeffrey R Tucker, MD Assistant Professor, Department of Pediatrics, Division of Emergency Medicine, University of Connecticut School of Medicine, Connecticut Children's Medical Center

Disclosure: Received salary from Merck for employment.

Chief Editor

Stephen L Thornton, MD Associate Clinical Professor, Department of Emergency Medicine (Medical Toxicology), University of Kansas Hospital; Medical Director, University of Kansas Hospital Poison Control Center; Staff Medical Toxicologist, Children’s Mercy Hospital

Stephen L Thornton, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology

Disclosure: Nothing to disclose.

Additional Contributors

Halim Hennes, MD, MS Division Director, Pediatric Emergency Medicine, University of Texas Southwestern Medical Center at Dallas, Southwestern Medical School; Director of Emergency Services, Children's Medical Center

Halim Hennes, MD, MS is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Timothy E Corden, MD Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin

Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, Wisconsin Medical Society

Disclosure: Nothing to disclose.

Acknowledgements

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Ryan J Petersen, MD, to the original writing and development of this article.

PCP Toxicity Differential Diagnoses

Differential Diagnoses

References

Tables

Contributor Information and Disclosures

What would you like to print?